About
Rosetta Omics is an innovative startup unlocking the road to precision medicine by tumor characterization via high resolution mass spectrometry profiling and AI in cancer patients.
Our mission is to help oncologists, clinicians, and pathologists to better diagnose, stratify and rank first line treatment options for cancer patients from one unique tissue slide per patient.
Rosetta Omics develops accurate predictive tests using AI to support with treatment choices for different types of cancer but also provide pharma R&D with patients molecular profile database for biomarkers validation and therapeutic targets exploration.
AREAS OF ACTIVITIES
BiotechnologyLife Sciences, Medicine & Pharmaceuticals